get a key
steadybase-$ company SNOA
account_id none on file
legal_name Sonoma Pharmaceuticals, Inc.
ticker SNOA
cik 1367083
domain sonomapharma.com
entry_point_account_id none on file
name Sonoma Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
hq Boulder, CO, United States
calls 0 filings 3 executives 8 family 0
why_nownone on file
callsnone on file
filings
Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2026.

filing / Aug 6, 2026 / receipt

of the Securities and Exchange Commission for smaller reporting companies, we determined that the following officers were our Named Executive

filing / Jul 28, 2026 / receipt

‘‘householding,’’ potentially provides extra convenience for stockholders and cost savings for us. Under this procedure, multiple stockholders who share the same last name and address will receive only one copy of the annual proxy materials, unless they notify us that they wish to continue receiving multiple copies.

filing / Jul 28, 2026 / receipt

executives
Bubba Sandford President - receipt
Dal Poggetto Executive Vice President - receipt
Jerry McLaughlin director - receipt
Philippe Weigerstorfer director - receipt
Russell Harrison director - receipt
Sameer Harish Chief Financial Officer - receipt
Sharon Barbari director - receipt
Vanessa Jacoby director - receipt
familynone on file
upcoming
2026-11-03 earnings call scheduled
changes
2026-01-28 director, appointed sec_8k
2023-07-14 Executive Vice President, appointed sec_8k
2018-12-14 President, appointed sec_8k
2018-09-19 director, appointed sec_8k
2014-04-01 director, appointed sec_8k
2014-02-26 director, appointed sec_8k
2013-03-07 director, appointed sec_8k
2013-02-04 Chief Financial Officer, appointed sec_8k
mcp_package_hint
steadybase-$